Metronidazole/Minocycline

甲硝唑/米诺环素

Report date: 2026/03/06 20:02:51

Base Information

Drug NameMetronidazole/Minocycline
Drug Alias NameYH-26153
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of ActionDNA synthesis inhibitors30S ribosomal subunit inhibitorsPoly (ADP-Ribose) polymerase 1 inhibitors
Targets30S ribosomal subunitPoly (ADP-Ribose) polymerase 1
Therapy Area/IndicationsPeri-Implantitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes MetronidazoleMinocycline Hydrochloride
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesYuhan Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYuhan Corp
Active IndicationsN/A
Inactive IndicationsPeri-Implantitis

Other Information

ATC CodeN/A
Related LinksN/A